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Abstract
Increased attention has been focused on marine invertebrates as a source of bioactive molecules for biomedical applications.
Many bioactive molecules are part of the innate immune system. Some more recently isolated compounds, mainly from the
sea urchin and the sea cucumber, are antimicrobial peptides (AMPs) active against Gram-positive and Gram-negative
bacteria, and fungi. In this review we described the most recent studies on AMPs isolated from echinoderms. AMPs are
small peptides (< 10 kDa) with cationic charge and amphipathic structure. Recently, it was demonstrated that in the
coelomocyte lysates of Paracentrotus lividus and Holothuria tubulosa, AMPs possess activity against staphylococcal and
Pseudomonas aeruginosa bioﬁlms. The data shows a great potential for application of AMPs in biotechnology for developing
novel therapeutic agents that are either alternative or complementary to conventional antibiotic therapy to combat multi-
resistant pathogens.
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Bioﬁlms and antimicrobial peptides
Bioﬁlms are a complex community of microbial cells,
enclosed in three-dimensional networks of microbial
cells embedded in a self-produced polymeric matrix
(slime) (Figure 1). The capacity to organize a bioﬁlm
community is present in almost all Gram-negative
and Gram-positive bacteria. The process of building
a bioﬁlm structure consists, generally, of four stages:
(1) adherence of planktonic cells to the abiotic surface
or tissue through weak van derWaals forces where the
colonists are anchored tightly or irreversibly by pili
(Pratt & Kolter 1998) (Figure 1a); (2) the microcolo-
nies’ recruitment of other planktonic cells and growth.
Normally, they are surrounded by a large amount of
extracellular polymeric protective matrix (extracellu-
lar polymeric substance: EPS) (Lawrence et al. 1991).
The matrix includes a wide variety of proteins, glyco-
proteins and glycolipids, and, in some cases, surpris-
ing amounts of extracellular DNA (e-DNA) (Hall-
Stoodley & Stoodley 2009), and can interact with
the environment, e.g., by attaching bioﬁlms to sur-
faces, and through its sorption properties, which allow
for sequestering of dissolved and particulate sub-
stances from the environment, providing nutrients
for bioﬁlm organisms and inﬂuencing predator-prey
interactions (Joubert et al. 2006). These components
are very important targets for overcoming both bio-
ﬁlms and drug-resistant bacteria (Hancock &
Diamond 2000), (Figure 1b). (3) Bioﬁlm maturation
involving the development of water channels and spe-
cialized zones (Figure 1c), and (4) dispersion of cells
and/or parts of the bioﬁlm with subsequent coloniza-
tion of other locations (Costerton et al. 1981; Donlan
& Costerton 2002; Fey 2010; Høiby et al. 2010)
(Figure 1d). The architecture of a mature bioﬁlm is
variable, ranging from ﬂat, homogeneous layers of
cells to highly organized cell clusters with a mush-
room-shaped structure containing water-ﬁlled chan-
nels (Wimpenny et al. 2000).
Although there is great scientiﬁc interest and there
have been important research advances in the bioﬁlm
area, we are still far from being able to control and
suppress bioﬁlms. Approximately 80% of human bac-
terial infections are caused by bioﬁlms (Harro et al.
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2010), mainly due to healthcare-associated infections
related to the implantation of medical devices, e.g.
urinary catheters, intravascular catheters and prosthe-
tic heart valves. As such, microbial adhesion onto
surfaces and the subsequent formation of bioﬁlms
are critical concerns for many biomedical applications
(Donlan & Costerton 2002; Fey 2010). Indeed, the
increasing resistance of bioﬁlms to traditional antimi-
crobial treatments is considered the major cause of
dissemination of antibiotic resistance in nosocomial
infections (Fey 2010; Spizek et al. 2010).
Antibiotics can be effective against planktonic
(free-living) pathogens but are quite often barely
effective against the bacteria organized in a commu-
nity, which can increase antibiotic resistance by 10–
1000 fold (Nickel et al. 1985; Evans & Holmes 1987;
Gristina et al. 1987; Prosser et al. 1987). It has been
estimated that bioﬁlms are associated with nosoco-
mial infections and represent the fourth leading
cause of death in the US with ~10% of American
hospital patients leading to more than $5 billion in
added medical costs per annum (Wenzel 2007). The
bacteria structured in bioﬁlms develop a multifactor-
ial mechanism of resistance to antibiotics (Obst et al.
2006) and there are several factors that contribute to
bioﬁlm resistance. The bioﬁlm environment allows a
higher frequency of mutation and horizontal gene
transmission when compared to planktonic bacteria,
which explains the rapid development of antibiotic
resistance in bioﬁlms (Ghigo 2001). Within the struc-
ture of the bioﬁlm are formed oxygen and nutrient
gradients, which cause some form of nutrient limita-
tion. This induces the bacteria to enter into a station-
ary phase, like dormancy, and under this form
bacteria are tolerant to antimicrobials (Brown et al.
1988; Wentland et al. 1996). The resistance can also
be due to a general stress response initiated by growth
within a bioﬁlm (Brown & Barker 1999). So, bacteria
can resist, protecting themselves from the detrimental
effects of heat shock, cold shock, changes in pH and
many chemical agents (Hengge-Aronis 1996). The
matrix is able to delay antibiotic penetration into the
bioﬁlm structure, which contains polymers that bind
to antibiotics and hinder their action, and antibiotic-
degrading enzymes that deactivate them (Hoyle et al.
1992; Tseng et al. 2013).
The difﬁculty of successfully treating bioﬁlm-asso-
ciated infections, and the increasing resistance of
microbes to traditional treatments, call for the dis-
covery of compounds with novel mechanisms of
action. Most of the antimicrobial products that
have been developed are derivatives of compounds
that are already known, and hit the same targets, so
their action can only be somewhat better. Now,
research is drifting towards the discovery of non-
traditional sources of antimicrobials, and a series of
natural compounds that exhibit antimicrobial activity
has been isolated in the past 20 years from many
plant, insect and animal species (Roch et al. 1996;
Andreu & Rivas 1998; Bulet et al. 1999; Zasloff
2002; Rosetto et al. 2003; Dalla Valle et al. 2013)
as defense molecules as humoral parts of the innate
immune response (Table I). Animals, in particular,
are the most important source of antimicrobial com-
pounds, and several hundreds of antimicrobial pep-
tides have been found in a wide range of invertebrate
and vertebrate species. These natural antimicrobial
substances, named antimicrobial peptides (AMPs),
stand out because they have a much higher hit rate in
high-throughput screens than the combinational
libraries of traditional antimicrobials. Moreover, nat-
ural products are usually much more complex than
synthetic products and present scaffolds with viable
and biologically validated starting points for the
design of chemical libraries (Spizek et al. 2010).
According to antimicrobial peptide databases, more
than 10,000 AMPs have been discovered to date
(Table I).
Figure 1. The cycle of bioﬁlm. (a) Attachment of planktonic cells to a surface; (b) recruitment of other planktonic cells and production of
extracellular polymeric substance (EPS); (c) growth and development of bioﬁlm through cell division and recruitment; (d) dispersion of
bacteria from bioﬁlm.
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The largest group of AMPs is that of cationic
molecules, which are widely distributed in animals
and plants. They have a small molecular size with no
more than 100 amino acids and a molecular weight <
10 kDa. They differ considerably in amino acid
sequence and structural conformation, and most of
them are positively charged, showing a net positive
charge of +2 to +9 due to an excess number of basic
amino acids like arginine or lysin, with 50% or more
of the amino acids hydrophobic and forming a
hydrophobic face opposite to a hydrophilic one
(Brogden 2005; Hancock & Sahl 2006). On the
basis of their structural features, cationic AMPs can
be divided into linear peptides forming α-helical
structures, cysteine-rich open-ended peptides con-
taining single or several disulﬁde bridges and mole-
cules rich in speciﬁc amino acids such as proline,
glycine or histidine. These chemo-physical charac-
teristics allow these peptides to be soluble in water
but react simultaneously with the hydrophobic layer
of microbial membranes. Such peptides are found in
all species of life including bacteria, fungi, plants,
insects, birds, crustaceans, amphibians and
mammals. A single animal can contain different
classes of peptides and a number of variants in a
given class.
The mode of action of AMPs has rarely been
addressed and is therefore not yet understood
(Brogden 2005). It is generally agreed that the pre-
valent mechanism of action of the AMPs is due to
their ability to permeabilize and/or to form pores
within the cytoplasmic membranes. AMPs are initi-
ally recruited on the microbial surface through elec-
trostatic interaction between the cationic portion of
the peptides and the negatively charged microbial
cell walls and/or membranes. Bacterial pathogens’
membranes are composed predominantly of phos-
phatidylglycerol, cardiolipin or phosphatidylserine
and tend to be highly electronegative. Studies sup-
port a non-receptor type interaction for antimicrobial
peptides with most pathogen membranes (Bessalle
et al. 1990; Wade et al. 1990). When the peptide/
lipid ratio increases, the peptides start forming multi-
mers or self-associating on top of the membrane.
When the peptides reach a high concentration, they
orientate perpendicularly and insert into the bilayer,
Table I. List of antimicrobial web databases.
Name
No. of listed
antimicrobial
peptides Origin Web address
4020 Prokaryotes and
eukaryotes
http://www.bicnirrh.res.in/
antimicrobial/
2525 Eukaryotes http://yadamp.unisa.it/default.aspx
1232 Prokaryotes and
eukaryotes
http://apps.sanbi.ac.za/dampd/
2308 Prokaryotes and
eukaryotes
http://aps.unmc.edu/AP/main.php
895 Eukaryotes http://www.bbcm.units.it/~tossi/
amsdb.html
177 Bacteriocin http://bactibase.pfba-lab-tun.org/
statistics.php
363 Defensin http://defensins.bii.a-star.edu.sg/
271 Plant http://phytamp.pfba-lab-tun.org/
main.php
Antimicrobial peptides 3
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ita
 di
 Pa
ler
mo
], 
[P
ro
fes
so
r V
inc
en
zo
 A
riz
za
] a
t 0
7:3
4 0
9 J
uly
 20
14
 
thereby interfering with membrane integrity. The
microorganisms are then destroyed via either mem-
brane destabilization and/or pore formation
(Brogden 2005; Yount et al. 2006), or through inter-
ference with several essential metabolic functions,
such as protein, nucleic acid and cell wall syntheses
acting on nucleic acids and/or enzymatic proteins,
leading to bacterial cell death (Kamysz et al. 2003;
Brogden 2005; Yount et al. 2006; Hale & Hancock
2007; Nicolas 2009). Moreover, it appears that many
AMPs may be multifunctional microbicides, acting
simultaneously at the cell membrane and internal
sites (Yount et al. 2006).
Recent research has shown that AMPs also have a
high potential for inhibiting the formation of or
destroying bioﬁlm. In fact, they can act at several
stages of bioﬁlm formation and with different
mechanisms of action: they may minimize the initial
adhesion of microbial cells to abiotic surfaces by
altering the adhesive features of abiotic surfaces,
reducing ﬂagellum-dependent swimming motility,
stimulating twitching motility, a type of surface moti-
lity that promotes the disassembly of bioﬁlm struc-
tures or by binding to microbial surfaces via
electrostatic interactions; they may prevent bioﬁlm
maturation by killing the early surface colonizers, or
by inhibiting quorum sensing (QS) – that is, the
communication system used by many bacteria to
build a bioﬁlm. QS is a system composed of small
molecules that control collective behaviors, such as
bioluminescence, virulence factor production and
bioﬁlm formation (Spoering & Gilmore 2006;
Horswill et al. 2007; Picioreanu et al. 2007; Huang
et al. 2010; Brogden & Brogden 2011; de la Fuente-
Nunez et al. 2012).
AMPs are produced by living organisms through-
out the bacteria and animal kingdoms, including also
fungi and plants (O’Keefe 2001; Rodriguez et al.
2002; Zasloff 2002; Castro & Fontes 2005; Cotter
et al. 2005; Riley & Chavan 2007; Strominger 2009;
da Rocha Pitta et al. 2010). Currently, more than
4000 peptides have been isolated and characterized
from tissues and organisms, and have been listed in
the main databases or in journal publications
(Thomas et al. 2010).
In invertebrates, AMPs are ubiquitously distribu-
ted, found especially in hemolymph and in tissues
such as epidermis, gut and respiratory organs where
exposure to pathogenic microorganisms is most
likely to occur, expressed constitutively or in
response to a pathogen stimulus. The AMPs defend
the organism not only through their ability to kill
bacteria, but it has been shown that they have anti-
tumor effects and mitogenic activity and, most
importantly, participate in immunoregulatory
mechanisms by modulating signal transduction and
cytokine production and/or release (Hancock &
Diamond 2000; Zasloff 2002; Bals & Wilson 2003;
Kamysz et al. 2003; Bowdish et al. 2005; Brown &
Hancock 2006; Hancock et al. 2006; Yount et al.
2006; Easton et al. 2009; Lai & Gallo 2009; Guani-
Guerra et al. 2010).
The purpose of this review will be to present the
most recent data on microbial antibioﬁlm peptides
isolated and characterized in the phylum
Echinodermata. In particular we will focus on their
structure and biological functions, and on their
potential application as antimicrobial and antibioﬁlm
agents to combat human pathogens.
Antimicrobial and antibioﬁlm peptides in
echinoderms
Echinoderms are deuterostome invertebrates, an
ancient group of marine invertebrates that live in
both the intertidal and deep-sea benthos, composed
of approximately 7000 extant species including sea
stars (asteroids), sea urchins (echinoids), sea cucum-
bers (holothurians), brittle stars (ophiuroids) and sea
lilies (crinoids). Because many species live in or near
the coastal or estuary waters overloaded with infec-
tious organisms – such as viruses, bacteria, fungi and
other parasites – they are exposed to a broad variety
of challenges to their self-integrity. They have
evolved efﬁcient defense strategies in order to survive
in these high-impact environments.
Echinoderms, similarly to other invertebrates, do
not possess a speciﬁc immune response. Therefore,
they ensure the protection of their organism and its
homeostasis using natural immunity responses.
The echinoderm humoral immune response con-
sists of the production of proteins that are seques-
tered within the cells, having hemolytic and
hemagglutinating properties (Canicattì 1987, 1988,
1992; Arizza et al. 2007), and also includes the
synthesis of AMPs that are secreted from the
coelomocyte.
Beauregard et al. (2001) discovered, for the ﬁrst
time in echinoderms, the presence of AMPs, a
peptide of ~ 6 kDa active against Gram-positive
and Gram-negative bacteria, in the coleomic ﬂuid
of the sea cucumber Cucumaria frondosa
(Gunnerus, 1767). Since 2001, the number of
such discovered molecules has increased steadily.
Stabili et al. (1996) found in coelomic ﬂuid and in
coelomocytes of Paracentrotus lividus (Lamarck,
1816) the effector cells of immunity, a peptide of
60 kDa that was able to inhibit the growth of
Vibrio alginolyticus. Other antimicrobial activity
was found in the jelly coat, in seminal plasma
4 D. Schillaci et al.
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(Stabili & Canicattì 1994) and in the larval lysate
of the same species (Stabili et al. 1994). In some
cases, antimicrobial proteins were also found in the
gastrointestinal organs and in the eggs of
Strongylocentrotus droebachiensis (Müller, 1776) and
Asterias rubens (Linnaeus, 1758) (Haug et al. 2002;
Li et al. 2008). Many AMPs are derived from
larger proteins that could be enzymatically digested
and produce active fragments. This has been
demonstrated by (Ghanbari et al. 2012). In fact,
digesting the tissues of sea cucumber Actinopyga
lecanora (Jaeger, 1833) with bromelain, peptides
with inhibitory activities against Pseudomonas sp.,
P. aeruginosa, and Escherichia coli, respectively,
were obtained and one papain-digested fraction
showed antibacterial activity against Staphylococcus
aureus. Maltseva et al. (2007) found that among
the AMPs isolated in the starﬁsh Asterias rubens,
two peptides were part of the histone molecule
H2A. Maltseva and co-workers also found that
two other peptides were fragments of actin, while
one peptide was a fragment of ﬁlamin A. Gowda
et al. (2008) showed that an agglutinin that can
agglutinate Gram-positive and Gram-negative bac-
teria exhibited strong antibacterial activity both
under in vivo and in vitro conditions. Defensin-
like peptides were isolated by Ng et al. (2013) in
Strongylocentrotus droebachiensis. In a recent study,
Li et al. (2010) showed, in S. droebachiensis, an
AMP heterodimer structure named centrocin.
Centrocins possess a strong activity, not only
against Gram-positive and Gram-negative bacteria,
but also against fungi and yeasts.
The simultaneous presence of diverse AMPs found
in the same echinoderms as S. droebachiensis, probably
acting in synergy or complementary to each other,
may provide the organisms with an extended defense
against a wide range of pathogenic microorganisms.
Such interactions have been reported, at least in vitro,
between different AMPs isolated from the horseshoe
crab (Iwanaga et al. 1998) and the oyster, Crassostrea
gigas (Thunberg, 1793) (Gueguen et al. 2009).
Recently, our research group has found novel
cationic peptides in the echinoderm species
Paracentrotus lividus and in Holothuria tubulosa
(Gmelin, 1788). They were isolated from coelomo-
cyte lysate supernatant and showed good activity in
preventing the bioﬁlm formation of important patho-
gens involved in human and animal diseases, like
staphylococcal or P. aeruginosa strains (Schillaci
et al. 2010, 2013).
The antimicrobial peptides were discovered in a
protein fraction at low molecular weight (< 5 kDa)
from acid extract of coelomocytes. P. lividus showed
a peptide, Paracentrin 1, of 1251.7, the peptide
belonging to a segment (9–19) of a β-thymosin, a
ubiquitous peptide that exerts several biological
effects such as the induction of metalloproteinases,
chemotaxis, angiogenesis and inhibition of inﬂam-
mation (Huff et al. 2001). The β thymosins are a
family of highly conserved polar 5-kDa peptides ori-
ginally thought to be thymic hormones. They are
present at high concentrations in almost every cell
from vertebrate phyla and have several biological
functions due to direct and indirect effects on the
actin cytoskeleton. β-Thymosin is also described as
one of the AMPs of platelets from animals, including
human beings (Tang et al. 2002). There is little
information about the function of thymosins in
invertebrates, but their presence has been reported
in marine invertebrates (Safer & Chowrashi 1997;
Saelee et al. 2013) and in insects where they are
up-regulated by microbial infections (Zhang et al.
2011). H. tubulosa possessed two peptides,
Holothuroidin 1 and Holothuroidin 2, whose mole-
cular weights are respectively 1389.5 and 1547.6 Da
(Schillaci et al. 2013).
The peptides of both species showed a similarity
with other antimicrobial peptides produced by dif-
ferent organisms. Indeed, Paracentrin 1 had a amino
acid sequence similarity of 38.46% with Jelleine-III,
a short peptide presenting a broad spectrum of activ-
ity against Gram-positive and Gram-negative bac-
teria, and also against yeasts present in the royal
jelly produced by Apis mellifera (Linnaeus, 1758)
worker bees (Fontana et al. 2004); both
Holothuroidin 1 and Holothuroidin 2 showed an
amino acid sequence similarity ≥ 35% respectively
with protonectins, peptides present in the venom of
the neotropical social wasp Agelaia pallipes
(Lepeletier, 1836), with a potent antimicrobial
action against both Gram-positive and Gram-nega-
tive bacteria (Mendes et al. 2004) and signiferins, a
naturally occurring cationic peptide produced by an
Australian frog, Crinia signifera (Girard, 1853), that
showed a wide spectrum of activity against Gram-
positive and Gram-negative bacteria including
Bacillus cereus, Enterococcus faecalis, Lactococcus lactis,
Listeria innocua, Micrococcus luteus, Staphylococcus
aureus, Staphylococcus epidermidis and Streptococcus
uberis (Maselli et al. 2004).
The peptides of both species had α-helix structures
with a considerable amphipathic character, with the
polar and mainly cationic residues segregated on one
polar face and the hydrophobic or nonpolar residues
on the opposite, apolar face. (Figure 2). They were
cationic peptides with a net charge of +0.9, with a
total hydrophobic ratio and deduced pI ranging
respectively from 36.36 and 8.72 for Paracentrin 1
to 42.86 and 7.56 for both Holothuroidins (Table II).
Antimicrobial peptides 5
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The activity of synthetic peptides constructed from
the sequences indicated by the tandem mass spectro-
metry (MS/MS) data were active against free-living
(planktonic) Gram-positive and Gram-negative
pathogens as Staphylococcus aureus, Staphylococcus
epidermidis and Pseudomonas aeruginosa (Table III)
(Schillaci et al. 2010).
The three echinoderm antimicrobial peptides were
also active to combat the bioﬁlm formation at sub-
minimum inhibitory concentration (MIC) concentra-
tions. Indeed, Paracentrin 1 was able to inhibit either
the formation of a young bioﬁlm (6-h old) of S. epider-
midis 1457 or the formation of a mature bioﬁlm (24 h
old) of the same clinical strain Figure 3 (Schillaci et al.
2010). The antimicrobial peptides from H. tubulosa
were able to inhibit the bioﬁlm formation of two staphy-
lococcal reference strains, S. aureus ATCC 25923 and
S. epidermidis ATCC 35984 (Schillaci et al. 2013).
We observed that synthetic Paracentrin 1,
Holothuroidin 1 and Holothuroidin 2 did not
show, in phosphate buffered saline (PBS), hemolytic
activity, probably because the high ionic strength of
PBS allows negatively charged sialic acid present on
the erythrocyte membrane to neutralize the peptides.
On the basis of this evidence, they could be classiﬁed
as peptide antibiotics (Saberwal & Nagaraj 1994).
Conclusions
AMPs are evolutionarily ancient defensive mole-
cules. Their extraordinary distribution in all king-
doms, within both unicellular and multicellular
organisms, suggests that they have a key and funda-
mental role in the biology of organisms that probably
has evolved through positive selection (Tennessen
Table III. Antimicrobial activity (MIC) of < 5-kDa peptide fraction from celomocytes lysate supernatant (Paracentrin 1) or
synthetic peptides (Holothuroidin 1 and 2). Values expressed in mg/mL.
Strain Paracentrin 1 Holothuroidin 1 Holothuroidin 2
Staphylococcus aureus ATCC 29213 126.8 > 12.5 12.5
Staphylococcus aureus ATCC 25923 63.4 12.5 12.5
Staphylococcus aureus ATCC 43866 63.4 nd nd
Staphylococcus aureus ATCC 6538 nd 12.5 12.5
Staphylococcus epidermidis ATCC 35984 nd 12.5 12.5
Enterococcus faecalis ATCC 29212 nd >12.5 12.5
Pseudomonas aeruginosa ATCC 15442 nd 12.5 12.5
(Schillaci et al. 2010) (Schillaci et al. 2013)
nd = not determined.
Figure 2. A ribbon representation of (A) Paracentrin 1, (B) Holoturoidin 1 and (C) Holoturoidin 2. The amphipathic nature of the peptide
is shown in this representation with the hydrophilic side above and the hydrophobic side below the polypeptide backbone. The potential
surface is superimposed. Color code: acidic residues in red, basic residues in blue and hydrophobic residues in white.
Table II. Chemical-physical characteristics and amino acid sequences of echinoderm antibioﬁlm peptides.
Peptides
Sequence, and hydrophobic
amino acids on
the sameface (underlined)
Molecular
weight (Da)
Net charge
(pH 7.0)
Total hydrophobic
ratio (%) pI
Paracentrin 1 EVASFDKSKLK 1251.4 +0.9 36.36 8.72
Holothuroidin 1 HLGHHALDHLLK 1389.5 +0.9 41.67 7.56
Holothuroidin 2 ASHLGHHALDHLLK 1547.6 +0.9 42.86 7.56
6 D. Schillaci et al.
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2005; Viljakainen & Pamilo 2008; Fernandes et al.
2010).
AMPs from marine invertebrates could play a
complementary but critical role in helping
acquired immunity in vertebrates to combat bac-
terial infections that normally confound and even
suppress the immune system with their sophisti-
cated and multiantigenic cycle of life (Chiu et al.
2013).
AMPs from marine invertebrates can be applied in
biotechnology and in medicine. These natural com-
pounds constitute potential candidates for the devel-
opment of alternative strategies to prevent and treat
bacterial infections, including bioﬁlm-associated
infections that are particularly resistant to conven-
tional antibiotics.
In conclusion, the discovery of novel peptides
in echinoderms represents a good starting point to
design new synthetic derivatives with modiﬁed
chemical-physical properties, with the aim
being to improve their antimicrobial activity
against pathogens, and their pharmaceutical
potential (Huang et al. 2010; Brogden &
Brogden 2011).
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